Bangladesh · Delayed Price · Currency is BDT Beacon Pharmaceuticals Company Description
Beacon Pharmaceuticals PLC engages in the producing and promoting of pharmaceuticals finished formulations, lifesaving intravenous fluids, active pharmaceutical ingredients, bio-tech, and genetic engineering products in Bangladesh and internationally.
The company offers general, oncology, biotech, and chronic care products. It also provides products in various therapeutic categories such as oncology, hematology, anti-cancer, hepatology, nephrology, antibiotics, analgesics, anti-diabetics, respiratory, cardiovascular, dermatology, gastrointestinal, infectious diseases, immunology, rheumatology, muscle relaxants, antihistamines, anti-coagulants, protein supplements, pediatrics, NSAIDs, nutritional supplements, and others.
In addition, the company offers contract and toll manufacturing services. It provides its products under the Pemro, Nivomab, Xelpac Premium, Docexan, Xaloplat Aqua, Gemoxen Aqua, ETP, FXR, Renesis, Mezest, Eposis, Tirza, Xelmet, Xerova, Sinjard, Ovocal, Haxinor, Tetrazin, Lubilux, Paloxi, Olonex, Gaviflux, Mirogab, Flexibac, and Bukof brand name.
Beacon Pharmaceuticals PLC was incorporated in 2001 and is based in Dhaka, Bangladesh.
| Country | Bangladesh |
| Founded | 2001 |
| Industry | Pharmaceutical Preparations |
| Employees | 4,771 |
| CEO | Ulfat Karim |
Contact Details
Address: Beacon Business Centre Dhaka, 1223 Bangladesh | |
| Phone | 880 2 41054 00510 |
| Website | beaconmedicare.com.bd |
Stock Details
| Ticker Symbol | BEACONPHAR |
| Exchange | Dhaka Stock Exchange |
| Fiscal Year | July - June |
| Reporting Currency | BDT |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Ulfat Karim | Chief Executive Officer |
| Jalal Uddin | Chief Financial Officer |